Skip to main content
. 2016 Dec 31;6:259–268. doi: 10.1016/j.omtn.2016.12.009

Figure 5.

Figure 5

AKSLHNs Enhance In Vivo Downregulation of K-ras G12S mRNA and Protein

(A) Western blot analysis shows an enhanced downregulation of target protein (K-ras mRNA) by AKSLHNs (nanoparticles) in comparison with PBS and combination treatment. Erlotinib-treated lung tumors also show some downregulation. (B) TaqMan qRT-PCR shows that AKSHLNs (nanoparticles) downregulated K-ras mRNA by approximately 50% in comparison with PBS. n = 3; **p ≤ 0.01; ***p ≤ 0.001. Error bars are ± SD.